224 related articles for article (PubMed ID: 38147007)
1. Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Saulters EL; Kennedy PT; Carter RJ; Alsufyani A; Jones TM; Woolley JF; Dahal LN
Cancer Res Commun; 2024 Jan; 4(1):118-133. PubMed ID: 38147007
[TBL] [Abstract][Full Text] [Related]
2. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
4. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
Smahel M; Nunvar J
Virol J; 2023 Dec; 20(1):287. PubMed ID: 38049810
[TBL] [Abstract][Full Text] [Related]
7. STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Lu S; Concha-Benavente F; Shayan G; Srivastava RM; Gibson SP; Wang L; Gooding WE; Ferris RL
Oral Oncol; 2018 Mar; 78():186-193. PubMed ID: 29496049
[TBL] [Abstract][Full Text] [Related]
8. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
Zhu D; He X; Li Y; Li G; Chen M
Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
[TBL] [Abstract][Full Text] [Related]
9. STINGing Viral Tumors: What We Know from Head and Neck Cancers.
Saulters E; Woolley JF; Varadarajan S; Jones TM; Dahal LN
Cancer Res; 2021 Aug; 81(15):3945-3952. PubMed ID: 33903123
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs.
Khan IN; Gibson-Corley KN; Coppock JD; Simons AL
Head Neck Pathol; 2022 Sep; 16(3):763-772. PubMed ID: 35334093
[TBL] [Abstract][Full Text] [Related]
11. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
12. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.
Mirghani H; Amen F; Tao Y; Deutsch E; Levy A
Cancer Treat Rev; 2015 Dec; 41(10):844-52. PubMed ID: 26476574
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
[TBL] [Abstract][Full Text] [Related]
14. New insights into human papillomavirus-associated head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Del Mistro A; Bussu F; Lupato V; Baboci L; Almadori G; DA Mosto MC; Paludetti G
Acta Otorhinolaryngol Ital; 2013 Apr; 33(2):77-87. PubMed ID: 23853396
[TBL] [Abstract][Full Text] [Related]
15. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
Chintala S; Quist KM; Gonzalez-DeWhitt PA; Katzenellenbogen RA
Head Neck; 2022 Jan; 44(1):177-188. PubMed ID: 34693597
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
17. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
18. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Murphy RM; Tasoulas J; Porrello A; Carper MB; Tsai YH; Coffey AR; Kumar S; Zeng PY; Schrank TP; Midkiff BR; Cohen S; Salazar AH; Hayward MC; Hayes DN; Olshan A; Gupta GP; Nichols AC; Yarbrough WG; Pecot CV; Amelio AL
Cancer Res Commun; 2022 Sep; 2(9):987-1004. PubMed ID: 36148399
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
[TBL] [Abstract][Full Text] [Related]
20. The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Zhou C; Parsons JL
Expert Rev Mol Med; 2020 Jul; 22():e3. PubMed ID: 32611474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
